What is the treatment for vertiginous migraine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Vertiginous Migraine (Vestibular Migraine)

For acute attacks of vestibular migraine, use triptans as first-line therapy when headache is present, and for prophylaxis in patients with frequent or disabling attacks, flunarizine should be considered the first-choice preventive medication based on randomized trial evidence. 1

Acute Attack Treatment

First-Line Acute Therapy

  • Triptans are the primary migraine-specific medication for acute vestibular migraine attacks, particularly when headache accompanies the vertigo. 1, 2
  • Begin with oral sumatriptan 50-100 mg at attack onset, which can be repeated after 2 hours if symptoms persist, with a maximum daily dose of 200 mg. 3
  • Alternative triptans include rizatriptan 10 mg, naratriptan 2.5 mg, or zolmitriptan 2.5-5 mg if sumatriptan is ineffective or poorly tolerated. 4
  • Treat early in the attack when symptoms are still mild to maximize efficacy, as delayed treatment reduces response rates. 5

Adjunctive Acute Therapy

  • Add vestibular suppressants during acute attacks to manage vertigo symptoms directly. 2, 6
  • Consider antiemetics such as metoclopramide 10 mg or prochlorperazine 10 mg for nausea, which also provide synergistic analgesia. 5, 4
  • NSAIDs (ibuprofen, naproxen sodium, or diclofenac potassium) can be used for mild-to-moderate attacks or combined with triptans to prevent symptom relapse. 5

Important Acute Treatment Caveat

  • Limit acute medication use to no more than 2 days per week to prevent medication-overuse headache, which affects both the headache and vestibular components. 4, 7
  • Many vestibular migraine patients present with monosymptomatic vertigo attacks without headache, making diagnosis challenging but not precluding triptan use. 8

Prophylactic Treatment

First-Line Preventive Therapy

  • Flunarizine is the first-choice preventive medication based on two randomized clinical trials demonstrating efficacy specifically for vestibular migraine. 1
  • Initiate preventive therapy when attacks occur more than twice weekly, cause significant disability, or when acute medication use becomes excessive. 5, 4

Second-Line Preventive Options

  • Propranolol is a well-established second-line option with evidence from general migraine prevention that extends to vestibular migraine. 1, 2
  • Venlafaxine (SNRI) is effective for patients who cannot tolerate beta-blockers or calcium channel blockers. 1, 2
  • Topiramate provides an alternative for patients requiring weight loss or those with comorbid epilepsy. 1, 2
  • Amitriptyline can be considered, particularly for patients with comorbid anxiety or sleep disturbance. 2

Refractory Cases

  • For patients failing first- and second-line preventive treatments, consider acetazolamide or lamotrigine as third-line options. 2
  • Valproic acid may be used but is absolutely contraindicated in women of childbearing potential. 5

Non-Pharmacological Treatment

Vestibular Rehabilitation

  • Vestibular rehabilitation therapy is a sound prophylactic treatment option that should be incorporated into the management plan, particularly for patients with persistent disequilibrium between attacks. 1, 2
  • This approach addresses both the acute vestibular dysfunction and helps prevent future attacks through habituation and compensation mechanisms. 1

Behavioral Interventions

  • Relaxation training, thermal biofeedback combined with relaxation, and cognitive-behavioral therapy are effective adjuncts that can be combined with preventive drug therapy. 4

Critical Diagnostic Considerations

Distinguishing Features

  • Vestibular migraine attacks last from seconds to days, with considerable variation in duration being characteristic. 8
  • Hearing loss should be absent in vestibular migraine; its presence suggests Menière's disease instead. 2
  • Symptoms typically worsen with activity and head movements, encompassing vertigo, disequilibrium, or imbalance. 2
  • During acute attacks, central spontaneous or positional nystagmus may be present, and less commonly, unilateral vestibular hypofunction. 6

Common Pitfalls to Avoid

  • Do not dismiss the diagnosis when headache is absent during vertigo attacks—approximately one-third of patients present with monosymptomatic vertigo without concurrent headache. 8
  • Avoid confusing vestibular migraine with Menière's disease; the key differentiator is the absence of hearing loss in vestibular migraine. 2
  • Do not allow patients to increase acute medication frequency in response to persistent symptoms, as this creates medication-overuse headache; instead, escalate to preventive therapy. 7

Treatment Efficacy Timeline

  • Preventive therapy requires 2-3 months for oral agents to demonstrate full efficacy, so counsel patients about this timeline to maintain adherence. 7
  • The safety of treating more than 4 headaches in a 30-day period with triptans has not been established, reinforcing the need for preventive therapy in frequent attackers. 3

References

Research

Current Treatment Options: Vestibular Migraine.

Current treatment options in neurology, 2017

Guideline

Migraine Treatment Algorithm

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Vertigo as a symptom of migraine.

Annals of the New York Academy of Sciences, 2009

Guideline

Acute Headache Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Vestibular migraine.

Handbook of clinical neurology, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.